The amount of the proposed IPO in the SPAC’s amended filing remains unchanged from the initial $200 million registration filed in November.
INSU III is targeting businesses providing insurance or insurance related services, with particular emphasis on insurance distribution businesses, regulated insurance or reinsurance businesses, and insurance related technology businesses. Read more.
Related Posts
Phoenix Biotech Adds PIPE, Adjusts CERo Deal Terms
CERo is an immunotherapy company seeking to advance the next generation of engineered T cell therapeutics that employ phagocytic mechanisms.
Cano Health to Merge with Jaws Acquisition
The transaction values Cano Health at an enterprise value of $4.4 billion and is expected to provide up to $1.49 billion in cash proceeds, including a fully committed PIPE of $800 million.
PepperLime Health Acquisition Registers for $150M IPO
The new SPAC is targeting businesses in consumer health and wellness.
Jeneration Acquisition Files for $300M IPO
The SPAC in the filing said it will "focus on those areas where we can best capitalize on our team’s expertise in technology and technology-enabled models in Asia, and particularly in Greater China, including in mobility, online services, software, e-commerce, AI, robotics and clean energy."